Ikarian Capital’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-138,277
| Closed | -$484K | – | 123 |
|
|
2023
Q4 | $484K | Hold |
138,277
| – | – | 0.05% | 63 |
|
|
2023
Q3 | $492K | Hold |
138,277
| – | – | 0.06% | 61 |
|
|
2023
Q2 | $805K | Hold |
138,277
| – | – | 0.13% | 49 |
|
|
2023
Q1 | $5.23M | Hold |
138,277
| – | – | 1.19% | 16 |
|
|
2022
Q4 | $4.12M | Hold |
138,277
| – | – | 0.99% | 22 |
|
|
2022
Q3 | $4.62M | Sell |
138,277
-1,166
| -0.8% | -$38.9K | 0.92% | 17 |
|
|
2022
Q2 | $5.58M | Sell |
139,443
-2,719
| -2% | -$109K | 1.02% | 14 |
|
|
2022
Q1 | $7.48M | Buy |
142,162
+7,606
| +6% | +$400K | 0.98% | 10 |
|
|
2021
Q4 | $7.45M | Hold |
134,556
| – | – | 1.11% | 11 |
|
|
2021
Q3 | $10.4M | Sell |
134,556
-1,286
| -0.9% | -$99.5K | 0.73% | 9 |
|
|
2021
Q2 | $17.6M | Hold |
135,842
| – | – | 1.43% | 4 |
|
|
2021
Q1 | $22.4M | Hold |
135,842
| – | – | 0.75% | 3 |
|
|
2020
Q4 | $31.8M | Buy |
135,842
+27,715
| +26% | +$6.49M | 1.4% | 1 |
|
|
2020
Q3 | $11.2M | Buy |
+108,127
| New | +$11.2M | 0.81% | 7 |
|